EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.1.4 | - |
Mus musculus |
3.1.1.4 | - |
Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.4 | bromoenol lactone | 40% inhibition at 0.05 mM | Homo sapiens | |
3.1.1.4 | bromoenol lactone | inhibits at 0.025 mM | Mus musculus | |
3.1.1.4 | methyl arachidonyl fluorophosphonate | 80% inhibition at 0.001 mM | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.1.1.4 | cytosol | - |
Mus musculus | 5829 | - |
3.1.1.4 | cytosol | - |
Homo sapiens | 5829 | - |
3.1.1.4 | membrane | - |
Mus musculus | 16020 | - |
3.1.1.4 | membrane | - |
Homo sapiens | 16020 | - |
3.1.1.4 | membrane | - |
Rattus norvegicus | 16020 | - |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.1.1.4 | 61000 | - |
cPLA2-gamma | Mammalia |
3.1.1.4 | 63000 | - |
63000 Da and 77000 Da, iPLA2-gamma, SDS-PAGE | Mammalia |
3.1.1.4 | 77000 | - |
63000 Da and 77000 Da, iPLA2-gamma, SDS-PAGE | Mammalia |
3.1.1.4 | 85000 | 88000 | - |
Rattus norvegicus |
3.1.1.4 | 85000 | 88000 | aggregated form | Mus musculus |
3.1.1.4 | 85000 | 88000 | aggregated form | Homo sapiens |
3.1.1.4 | 85000 | 88000 | iPLA2 | Mammalia |
3.1.1.4 | 88000 | - |
iPLA2-gamma, calculated from amino acid sequence | Mammalia |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.4 | Homo sapiens | - |
- |
- |
3.1.1.4 | Mammalia | - |
- |
- |
3.1.1.4 | Mus musculus | - |
- |
- |
3.1.1.4 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.4 | muscle | - |
Rattus norvegicus | - |
3.1.1.4 | P-388D1 cell | macrophage-like cell line | Mus musculus | - |
3.1.1.4 | U937 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.4 | 1,2-dipalmitoyl-sn-glycero-3-phosphorylcholine + H2O | in mixed micelles with Triton X-100 | Mus musculus | 1-palmitoyl-sn-glycero-3-phosphorylcholine + palmitic acid | - |
? | |
3.1.1.4 | 1,2-dipalmitoyl-sn-glycero-3-phosphorylcholine + H2O | in mixed micelles with Triton X-100 | Homo sapiens | 1-palmitoyl-sn-glycero-3-phosphorylcholine + palmitic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine + H2O | in mixed micelles with Triton X-100 | Mus musculus | 1-palmitoyl-sn-glycero-3-phosphorylcholine + arachidonic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine + H2O | in mixed micelles with Triton X-100 | Homo sapiens | 1-palmitoyl-sn-glycero-3-phosphorylcholine + arachidonic acid | - |
? | |
3.1.1.4 | additional information | enzyme exhibits lyspohospholipase activity, lysophospholipid transacylase acitivty and phospholipase A2 activity | Mus musculus | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.1.1.4 | oligomer | - |
Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.4 | cPLA2-gamma | - |
Mammalia |
3.1.1.4 | Group VIA Ankyrin-1 | syn: iPLA2-1, splice variant of iPLA2 | Homo sapiens |
3.1.1.4 | Group VIA Ankyrin-2 | syn: iPLA2-2, splice variant of iPLA2 | Homo sapiens |
3.1.1.4 | Group VIA PLA2 | - |
Mus musculus |
3.1.1.4 | Group VIA PLA2 | - |
Homo sapiens |
3.1.1.4 | Group VIA-3 | syn: iPLA2-2, splice variant of iPLA2 | Homo sapiens |
3.1.1.4 | iPLA2 | - |
Mammalia |
3.1.1.4 | iPLA2-gamma | - |
Mammalia |